Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many YearsIlaria Muller, Marian Ludgate, Sarah Healy et al.|Thyroid|2018Cited by 33